PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.
10.1158/1535-7163.MCT-16-0739
Saved in:
Main Authors: | Chen, Luxi, Yuan, Yi, Kar, Shreya, Kanchi, Madhu M, Arora, Suruchi, Kim, Ji E, Koh, Pei F, Yousef, Einas, Samy, Ramar P, Shanmugam, Muthu K, Tuan Z, Shin, Sung W, Arfuso, Frank, Shen, Han M, Yang, Henry, Goh, Boon C, Park, Joo I, Gaboury, Louis, Lobie, Peter E, Sethi, Gautam, Lim, Lina HK, Kumar, Alan P |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/176793 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER
by: CHEN LUXI
Published: (2013) -
ROLE OF ANNEXIN-1 IN PATHOGEN RECOGNITION AND IMMUNE RESPONSE
by: SHU SHIN LA
Published: (2013) -
Carnitine and protein-calorie status in patients with carcinoma of the larynx
by: Oravan Saeuei
Published: (2023) -
USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7
by: Kit Leng Lui, S, et al.
Published: (2020) -
Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment
by: Moraes L.A., et al.
Published: (2020)